Vaped Phenanthrene
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 30 Jun 2028
- Type of study
- Interventional
- Treatments tested
- D10-phenanthrene
- Record updated
- 3 September 2026
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- > 21 years of age
- In good physical \& mental health
- In stable physical \& mental health
- Have tried vaping
- Former daily cigarette smokers who quit 1-20 year ago
- Non-smokers who have not used tobacco or nicotine products
Who cannot take part
- Has experience negative effects when vaped previously
- Has any respiratory disease (ex - asthma, COPD, etc...)
- Has/had liver disease
- Has/had cancer
- Has/had high blood pressure
- Pregnant or nursing
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Aleksandra AlchevaTaking people
About the trial
What the trial wants to find out
Some people who used to smoke cigarettes continue to be at higher risk of developing lung cancer, even years after quitting. This study will look to see if a specific chemical, phenanthrene, is broken down in the lungs of former smokers through more harmful pathways than never-smokers. If former smokers break down chemicals that enter their lungs through more harmful pathways this might be putting them at higher risk for developing lung cancer even though they quit smoking. This information may help find better ways to prevent or treat cancer in the future.
Read full original descriptionShow less
This study is under an IND, but the drug is not being studied; instead, it is being used as a marker for drug metabolism.
The group in the trial
- D10-phenanthreneOther group
All study participants (Former Daily Smokers and Non-smokers) will be asked to vape D10-phenanthrene to see how their lungs breakdown a class of cancer-causing chemicals known as polycyclic aromatic hydrocarbons \[PAHs\].
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Investigating Vaped Phenanthrene Biomarkers in Former Smokers
- Record updated
- 3 September 2026